200 related articles for article (PubMed ID: 11477137)
1. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
[TBL] [Abstract][Full Text] [Related]
2. Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.
Ly A; Francois JC; Upegui-Gonzalez LC; Swiercz B; Bedel C; Duc HT; Bout D; Trojan J
Life Sci; 2000 Dec; 68(3):307-19. PubMed ID: 11191646
[TBL] [Abstract][Full Text] [Related]
3. IGF-I triple helix gene therapy of rat and human gliomas.
Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
[TBL] [Abstract][Full Text] [Related]
4. Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis.
Ly A; Bouchaud C; Henin D; Sanson M; Delattre JY; Pan Y; Anthony D; Duc HT; Evrard P; Trojan J
Neurosci Lett; 2000 Mar; 281(1):13-6. PubMed ID: 10686404
[TBL] [Abstract][Full Text] [Related]
5. IGF-I triple helix strategy in hepatoma treatment.
Upegui-Gonzalez LC; Ly A; Sierzega M; Jarocki P; Trojan L; Duc HT; Pan Y; Shevelev A; Henin D; Anthony D; Nowak W; Popiela T; Trojan J
Hepatogastroenterology; 2001; 48(39):660-6. PubMed ID: 11462897
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
[TBL] [Abstract][Full Text] [Related]
7. Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA.
Trojan J; Duc HT; Upegui-Gonzalez LC; Hor F; Guo Y; Anthony D; Ilan J
Neurosci Lett; 1996 Jul; 212(1):9-12. PubMed ID: 8823750
[TBL] [Abstract][Full Text] [Related]
8. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.
Trojan J; Johnson TR; Rudin SD; Ilan J; Tykocinski ML; Ilan J
Science; 1993 Jan; 259(5091):94-7. PubMed ID: 8418502
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy of tumors expressing IGF-I].
Trojan J; Duc HT; Lafarge-Frayssinet C; Upegui-Gonzales LC; Swiercz B; Bismuth H; Hor F; Anthony D; Guo Y; Ilan J
C R Seances Soc Biol Fil; 1996; 190(1):165-9. PubMed ID: 8881277
[TBL] [Abstract][Full Text] [Related]
11. IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.
Trojan LA; Kopinski P; Wei MX; Ly A; Glogowska A; Czarny J; Shevelev A; Przewlocki R; Henin D; Trojan J
Acta Biochim Pol; 2002; 49(4):979-90. PubMed ID: 12545204
[TBL] [Abstract][Full Text] [Related]
12. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
Lafarge-Frayssinet C; Duc HT; Frayssinet C; Sarasin A; Anthony D; Guo Y; Trojan J
Cancer Gene Ther; 1997; 4(5):276-85. PubMed ID: 9345599
[TBL] [Abstract][Full Text] [Related]
13. Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model.
Shevelev A; Burfeind P; Schulze E; Rininsland F; Johnson TR; Trojan J; Chernicky CL; Hélène C; Ilan J; Ilan J
Cancer Gene Ther; 1997; 4(2):105-12. PubMed ID: 9080119
[TBL] [Abstract][Full Text] [Related]
14. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.
Trojan J; Blossey BK; Johnson TR; Rudin SD; Tykocinski M; Ilan J; Ilan J
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4874-8. PubMed ID: 1594587
[TBL] [Abstract][Full Text] [Related]
15. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.
Rininsland F; Johnson TR; Chernicky CL; Schulze E; Burfeind P; Ilan J
Proc Natl Acad Sci U S A; 1997 May; 94(11):5854-9. PubMed ID: 9159164
[TBL] [Abstract][Full Text] [Related]
16. Human glioma immunobiology in vitro: implications for immunogene therapy.
Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of the antisense and triplex anti-IGF-1 techniques for postoperative cellular gene therapy of malignant gliomas expressing IGF-1].
Kasprzak HA; Trojan J; Bierwagen M; Kopiński P; Jarocki P; Bartczak K; Czapiewska J
Neurol Neurochir Pol; 2006; 40(6):509-15; discussion 516. PubMed ID: 17199177
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor.
Morioka J; Kajiwara K; Yoshikawa K; Ideguchi M; Uchida T; Ohmoto Y; Suzuki M
J Neurooncol; 2002 Oct; 60(1):13-23. PubMed ID: 12416541
[TBL] [Abstract][Full Text] [Related]
19. Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.
Pan Y; Trojan J; Guo Y; Anthony DD
PLoS One; 2013; 8(3):e58428. PubMed ID: 23526983
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA.
Ellouk-Achard S; Djenabi S; De Oliveira GA; Desauty G; Duc HT; Zohair M; Trojan J; Claude JR; Sarasin A; Lafarge-Frayssinet C
J Hepatol; 1998 Nov; 29(5):807-18. PubMed ID: 9833920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
